![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
RB Rothman, JB Long, V Bykov, AE Jacobson, KC Rice and JW Holaday
Laboratory of Preclinical Pharmacology, St. Elizabeths Hospital, Washington, District of Columbia.
beta-Funaltrexamine (beta-FNA) is an alkylating derivative of naltrexone. Considerable data support its use as an irreversible mu receptor antagonist. However, pretreatment of rats with beta-FNA attenuates the ability of delta antagonists and naloxone to reverse delta receptor-mediated physiological effects, suggesting that physically adjacent mu and delta receptors interact in vivo. The purpose of this study was to determine which opiate receptor subtype is altered by i.c.v. injections of beta-FNA, as well as by in vitro incubations with beta-FNA, and then to examine the hypothesis that pretreatment of rats with beta-FNA increases the IC50 for naloxone at the altered binding site. The results demonstrate that beta-FNA alters the conformation of the opiate receptor complex, as evidenced by a decrease in the Bmax of the lower affinity [3H]D-Ala2-D-Leu5-enkephalin binding site and a doubling of the naloxone IC50 for displacing [3H]D- Ala3-D-Leu5-enkephalin from this site. [3H]D-Ala2-MePhe4,Gly-ol5- enkephalin binding sites were not detectably altered by i.c.v. injections of beta-FNA. These data collectively support the concept of coupling among opioid receptor subtypes.
This article has been cited by other articles:
|
|
 |
|
  W. J. Meilandt, E. Barea-Rodriguez, S. A. K. Harvey, and J. L. Martinez Jr Role of Hippocampal CA3 {micro}-Opioid Receptors in Spatial Learning and Memory J. Neurosci., March 24, 2004; 24(12): 2953 - 2962. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. F. Agnati, S. Ferre, C. Lluis, R. Franco, and K. Fuxe Molecular Mechanisms and Therapeutical Implications of Intramembrane Receptor/Receptor Interactions among Heptahelical Receptors with Examples from the Striatopallidal GABA Neurons Pharmacol. Rev., September 1, 2003; 55(3): 509 - 550. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Poonyachoti, P. S. Portoghese, and D. R. Brown Pharmacological Evidence for a 7-Benzylidenenaltrexone-Preferring Opioid Receptor Mediating the Inhibitory Actions of Peptidic delta - and {micro}-Opioid Agonists on Neurogenic Ion Transport in Porcine Ileal Mucosa J. Pharmacol. Exp. Ther., April 12, 2001; 297(2): 672 - 679. [Abstract] [Full Text]
|
|
|
|
 |
|
 N. A. Martin and P. L. Prather Interaction of Co-Expressed {micro}- and {delta}-Opioid Receptors in Transfected Rat Pituitary GH3 Cells Mol. Pharmacol., April 1, 2001; 59(4): 774 - 783. [Abstract] [Full Text]
|
|
|
|
|
|
G. L. Fraser, A. A. Pradhan, P. B. S. Clarke, and C. Wahlestedt Supraspinal Antinociceptive Response to [D-Pen2,5]-Enkephalin (DPDPE) Is Pharmacologically Distinct from That to Other delta -Agonists in the Rat J. Pharmacol. Exp. Ther., December 1, 2000; 295(3): 1135 - 1141. [Abstract] [Full Text]
|
|
|
|
 |
|
 S. Cvejic and L. A. Devi Dimerization of the delta Opioid Receptor:. IMPLICATION FOR A ROLE IN RECEPTOR INTERNALIZATION J. Biol. Chem., October 24, 1997; 272(43): 26959 - 26964. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Hepburn, P. J. Little, J. Gingras, and C. M. Kuhn J. Pharmacol. Exp. Ther., June 1, 1997; 281(3): 1350 - 1356. [Abstract] [Full Text]
|
|
|
|
|
|
C. Chen, J. Yin, J. K. d. Riel, R. L. DesJarlais, L. F. Raveglia, J. Zhu, and L.-Y. Liu-Chen Determination of the Amino Acid Residue Involved in [3H]beta -Funaltrexamine Covalent Binding in the Cloned RatµOpioid Receptor J. Biol. Chem., August 30, 1996; 271(35): 21422 - 21429. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Chen, J.-C. Xue, J. Zhu, Y.-W. Chen, S. Kunapuli, J. K. d. Riel, L. Yu, and L.-Y. Liu-Chen Characterization of Irreversible Binding of [IMAGE]-Funaltrexamine to the Cloned Rat µ Opioid Receptor J. Biol. Chem., July 28, 1995; 270(30): 17866 - 17870. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. R. George, T. Fan, Z. Xie, R. Tse, V. Tam, G. Varghese, and B. F. O'Dowd Oligomerization of {micro}- and delta -Opioid Receptors. GENERATION OF NOVEL FUNCTIONAL PROPERTIES J. Biol. Chem., August 18, 2000; 275(34): 26128 - 26135. [Abstract] [Full Text] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
